| Open source drug discovery with the malaria box compound collection for neglected diseases and beyond WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ... PLoS pathogens 12 (7), e1005763, 2016 | 294 | 2016 |
| Repurposing drugs for the treatment and control of helminth infections G Panic, U Duthaler, B Speich, J Keiser International Journal for Parasitology: Drugs and Drug Resistance 4 (3), 185-200, 2014 | 197 | 2014 |
| Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni FC Lombardo, V Pasche, G Panic, Y Endriss, J Keiser Nature Protocols 14 (2), 461-481, 2019 | 92 | 2019 |
| Orally active antischistosomal early leads identified from the open access malaria box K Ingram-Sieber, N Cowan, G Panic, M Vargas, NR Mansour, QD Bickle, ... PLoS neglected tropical diseases 8 (1), e2610, 2014 | 86 | 2014 |
| Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni G Panic, M Vargas, I Scandale, J Keiser PLoS neglected tropical diseases 9 (7), e0003962, 2015 | 81 | 2015 |
| Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 … JT Coulibaly, G Panic, KD Silué, J Kovač, J Hattendorf, J Keiser The Lancet Global Health 5 (7), e688-e698, 2017 | 78 | 2017 |
| Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome PHH Schneeberger, JT Coulibaly, G Panic, C Daubenberger, ... Parasites & vectors 11, 1-12, 2018 | 70 | 2018 |
| Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays G Panic, D Flores, K Ingram-Sieber, J Keiser Parasites and Vectors 8, 624, 2015 | 44 | 2015 |
| Effects of improved water, sanitation, and hygiene and improved complementary feeding on environmental enteric dysfunction in children in rural Zimbabwe: A cluster-randomized … EK Gough, LH Moulton, K Mutasa, R Ntozini, RJ Stoltzfus, FD Majo, ... PLoS neglected tropical diseases 14 (2), e0007963, 2020 | 37 | 2020 |
| Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium J Hess, G Panic, M Patra, L Mastrobuoni, B Spingler, S Roy, J Keiser, ... ACS infectious diseases 3 (9), 645-652, 2017 | 36 | 2017 |
| Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections J Keiser, G Panic, R Adelfio, N Cowan, M Vargas, I Scandale Parasites & vectors 9, 1-10, 2016 | 34 | 2016 |
| Impedance-based microfluidic assay for automated antischistosomal drug screening K Chawla, MM Modena, PS Ravaynia, FC Lombardo, M Leonhardt, ... ACS sensors 3 (12), 2613-2620, 2018 | 24 | 2018 |
| Pharmacokinetics of praziquantel in Schistosoma mansoni-and Schistosoma haematobium-infected school-and preschool-aged children J Kovač, I Meister, A Neodo, G Panic, JT Coulibaly, C Falcoz, J Keiser Antimicrobial agents and chemotherapy 62 (8), 10.1128/aac. 02253-17, 2018 | 23 | 2018 |
| Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind … JT Coulibaly, G Panic, RB Yapi, J Kovač, B Barda, YK N’Gbesso, ... BMC medicine 16, 1-10, 2018 | 21 | 2018 |
| Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice G Panic, MT Ruf, J Keiser Antimicrobial Agents and Chemotherapy 61 (12), e01142-17, 2017 | 21 | 2017 |
| Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal J Keiser, G Panic, M Vargas, C Wang, Y Dong, N Gautam, ... Journal of Antimicrobial Chemotherapy 70 (6), 1788-1797, 2015 | 21 | 2015 |
| Metabolic maturation in the first 2 years of life in resource-constrained settings and its association with postnatal growth N Giallourou, F Fardus-Reid, G Panic, K Veselkov, BJJ McCormick, ... Science Advances 6 (15), eaay5969, 2020 | 20 | 2020 |
| Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads G Panic, J Keiser Current opinion in pharmacology 42, 27-33, 2018 | 20 | 2018 |
| Evaluation of a novel micro-sampling device, MitraTM, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural … J Kovac, G Panic, A Neodo, I Meister, JT Coulibaly, JD Schulz, J Keiser J Pharm Biomed Anal 151, 339-346, 2018 | 19 | 2018 |
| Evaluation of a novel micro-sampling device, Mitra™, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural … J Kovač, G Panic, A Neodo, I Meister, JT Coulibaly, JD Schulz, J Keiser Journal of pharmaceutical and biomedical analysis 151, 339-346, 2018 | 17 | 2018 |
Jonathan SwannUniversity of Southampton, Imperial College LondonVerified email at soton.ac.uk
